Glaxo’s Tykerb Under Pharmaceutical Benefits Scheme for Cancer Patients in Australia

by Medindia Content Team on  April 9, 2008 at 2:39 PM Cancer News   - G J E 4
Glaxo’s Tykerb Under Pharmaceutical Benefits Scheme for Cancer Patients in Australia
Acknowledging the efficacy of Glaxo's Tykerb in fighting cancer, the federal government of Australia has chosen to make it available under the pharmaceutical benefits scheme.

The Pharmaceutical Benefits Scheme or PBS provides subsidised prescription drugs to residents of Australia. It seeks to ensure affordable and reliable access to a wide range of medicines.

Health Minister Nicola Roxon said Tuesday that Tykerb would be listed on the Pharmaceutical Benefits Scheme from May 1 for patients fighting advanced HER-2 breast cancer.

The drug has been found to improve symptoms and slow the progression of the particularly aggressive cancer, which claims the lives of 87 per cent of sufferers within five years.

Ms Roxon said about 2000 Australians were diagnosed with HER-2 positive breast cancer each year.

"HER-2 positive breast cancer is one that has spread to distant parts of the body or which cannot be removed with surgery," she said.

At $4000 a month, the treatment had been too expensive for many sick women to afford.

The drug's manufacturer, GlaxoSmithKline, had been providing its own subsidy to ensure women had access to Tykerb, however the arrangement was due to expire on May 31.

Its listing is expected to cost $10 million a year.

Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions
A/rahman Shacir wrote:

I am Mr. Abdirahman Sheik Mahamoud, Somali resident in Mogadishu the capital of war torn country is suffering a CARCINOID TUMOR.

My country there is no ONCOLOGY UNITS at all, Secondly the recent figthting destroyed all the hospitals, and I am in need for your help.


For your information, I had my operation in UAE Iranian hospital in 9/10/07 Dubai, then, the histopathology result announced a tumor.


0.1mg/ml octreotid, I was prescribed a 4 months which is 180inj , i.e. 3 times daily.

I was luckily donated a 2 months dosage which is 180pcs injection.

.therefore, I am kindly begging to you to assist me to get the remaining 180pcs since it cannot be found in my country, and I cannot afford to buy it. I am poor Somali/ living in an occupied civil war torn country.

waiting your help,

guest Tuesday, May 27, 2008

You May Also Like